The Present and Future of Mitochondrial-Based Therapeutics for Eye Disease.

Autor: Ji MH; Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA., Kreymerman A; Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA.; Stanford Cardiovascular Institute, Stanford University School of Medicine, Palo Alto, CA, USA., Belle K; Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA., Ghiam BK; Department of Ophthalmology and Visual Sciences, Case Western Reserve University, Cleveland, OH, USA., Muscat SR; Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA., Mahajan VB; Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA., Enns GM; Department of Pediatrics, Division of Medical Genetics, Stanford University School of Medicine, Palo Alto, CA, USA., Mercola M; Stanford Cardiovascular Institute, Stanford University School of Medicine, Palo Alto, CA, USA., Wood EH; Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA.; Stanford Cardiovascular Institute, Stanford University School of Medicine, Palo Alto, CA, USA.

Publikováno v: Translational vision science & technology [Transl Vis Sci Technol] 2021 Jul 01; Vol. 10 (8), pp. 4.